Scientific American

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...

FDA declines to review Moderna's mRNA flu shot

The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...

FDA refuses to review Moderna’s application for mRNA flu vaccine, company says

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
Opinion
Public Broadcasting Service (PBS)Opinion

U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says

The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...

Moderna says FDA refuses its application for new mRNA flu vaccine

It’s rare that FDA refuses to file an application, particularly for a new vaccine, which requires companies and FDA staff to engage in months or years of discussions. Moderna has requested an urgent ...